Anthelmintic effects of some medicinal plants on different life stages of Fasciola hepatica: Evidence on oxidative stress biomarkers, and DNA damage
- PMID: 38885188
- PMCID: PMC11182539
- DOI: 10.1371/journal.pntd.0012251
Anthelmintic effects of some medicinal plants on different life stages of Fasciola hepatica: Evidence on oxidative stress biomarkers, and DNA damage
Abstract
Fasciolosis caused by Fasciola hepatica is a major public health and economic problem worldwide. Due to the lack of a successful vaccine and emerging resistance to the drug triclabendazole, alternative phytotherapeutic approaches are being investigated. This study investigated the in vitro anthelmintic activity of Lavender (Lavandula angustifolia) and carob (Ceratonia siliqua L.) essential oils (EOs) against F. hepatica. The in vitro study was based on an egg hatch assay (EHA), adult motility inhibition assays, DNA damage, reactive oxygen species (ROS) level along with several oxidative stress biomarkers including glutathione peroxidase (GSH), and glutathione-S-transferase (GST), superoxide dismutase (SOD) and malondialdehyde (MDA). To this end, different concentrations of L. angustifolia and C. siliqua EOs (1, 5, 10, 25 and 50 mg/mL) were used to assess anthelmintic effects on different life stages including egg, and adults of F. hepatica for 24 hrs. The results indicated that these EOs play a significant role as anthelminthics, and the effect was dependent on time and concentration. The in vitro treatment of F. hepatica worms with both L. angustifolia and C. siliqua EOs increased DNA damage, ROS production and induction of oxidative stress (decreased SOD, GST and GSH, and increased MDA), significantly compared to control. Therefore, it can be concluded that L. angustifolia and C. siliqua EOs have the potential to be used as novel agents for the control and treatment of F. hepatica infections. Further studies are required to investigate their pharmacological potential and effectiveness in vivo for the treatment of parasitic infections.
Copyright: © 2024 Allahyari et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
In vitro assessment of the anthelmintic activity of copper oxide and zinc oxide nanoparticles on egg and adult stages of Fasciola hepatica: evidence on oxidative stress biomarkers, and DNA damage.BMC Vet Res. 2024 Apr 4;20(1):137. doi: 10.1186/s12917-024-03994-0. BMC Vet Res. 2024. PMID: 38575964 Free PMC article.
-
In Vitro anthelmintic efficacy of medicinal plant essential oils against Marshallagia marshalli: Evidence on oxidative/nitrosative stress biomarkers, DNA damage, and egg hatchability.Vet Parasitol. 2024 Apr;327:110138. doi: 10.1016/j.vetpar.2024.110138. Epub 2024 Jan 24. Vet Parasitol. 2024. PMID: 38286059
-
In vitro effects of triclabendazole (TCBZ) on the excretory-secretory products (ESP) of Fasciola spp parasites.Acta Med Iran. 2012;50(3):164-8. Acta Med Iran. 2012. PMID: 22418984
-
An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):465-474. doi: 10.1016/j.ijpddr.2018.10.009. Epub 2018 Oct 26. Int J Parasitol Drugs Drug Resist. 2018. PMID: 30399512 Free PMC article.
-
Current Threat of Triclabendazole Resistance in Fasciola hepatica.Trends Parasitol. 2016 Jun;32(6):458-469. doi: 10.1016/j.pt.2016.03.002. Epub 2016 Apr 2. Trends Parasitol. 2016. PMID: 27049013 Review.
Cited by
-
In vitro evaluation of the susceptibility of Echinococcus granulosus hydatid cysts to lavender and green tea extracts.Sci Rep. 2025 Jul 1;15(1):21778. doi: 10.1038/s41598-025-06979-7. Sci Rep. 2025. PMID: 40594647 Free PMC article.
References
-
- Mas-Coma S, Valero MA, Bargues MD. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol. 2009;69: 41–146. - PubMed
-
- Lima W dos S, Soares LRM, Barçante TA, Guimaraes MP, Barçante JM de P. Occurrence of Fasciola hepatica (Linnaeus, 1758) infection in Brazilian cattle of Minas Gerais, Brazil. Revista Brasileira de Parasitologia Veterinária. 2009;18: 27–30. - PubMed
-
- Rehman A, Ullah R, Gupta D, Khan MAH, Rehman L, Beg MA, et al.. Generation of oxidative stress and induction of apoptotic like events in curcumin and thymoquinone treated adult Fasciola gigantica worms. Exp Parasitol. 2020;209: 107810. - PubMed
-
- Kelley JM, Elliott TP, Beddoe T, Anderson G, Skuce P, Spithill TW. Current threat of triclabendazole resistance in Fasciola hepatica. Trends Parasitol. 2016;32: 458–469. - PubMed
-
- Martínez-Valladares M, Robles-Pérez D, Martínez-Pérez JM, Cordero-Pérez C, Famularo M del R, Fernández-Pato N, et al.. Prevalence of gastrointestinal nematodes and Fasciola hepatica in sheep in the northwest of Spain: relation to climatic conditions and/or man-made environmental modifications. Parasit Vectors. 2013;6: 1–9. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials